Mxd3 is over-expressed in multiple cancers, including acute lymphocytic leukemia and glioblastoma (Figure 2 and Figure 3) [271] and at least 17 different tumor types show survival differences that correlate with MXD3 expression levels (Figure 3). Here, MXD3 is linked to cancer.